Case Study: Alzheimer’s Research UK Oxford Drug Discovery Institute accelerates Alzheimer’s target discovery with Ontotext Target Discovery

Alzheimer’s Research UK Oxford Drug Discovery Institute speeds target analysis 6x with Ontotext

Alzheimer's Research UK Oxford Drug Discovery Institute faced the challenge of accelerating its assessment of novel Alzheimer's disease targets. The team had to manually screen vast amounts of sparse and scattered public data for 54 pre-selected genes, a laborious process that created a significant backlog and slowed down scientific breakthroughs. To address this, they turned to Ontotext and its AI-powered Target Discovery solution.

Ontotext implemented its Target Discovery platform, which consolidated data from over 30 sources into a single, user-friendly system with advanced analytics. This solution enabled the institute to quickly prioritize high-confidence targets based on custom criteria, streamlining the screening process. The results accelerated target analysis and decision-making, reducing a process that would normally take months to a much shorter timeframe and requiring only 1-2 people instead of a larger team, thereby optimizing resources and expediting lab validation.

Alzheimer’s Research UK Oxford Drug Discovery Institute